Clinical trials
Phase 2 Heart Failure trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2013 | 3 |
| 2017 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Terminated | 3 |
| Recruiting | 2 |
| Active, not recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bayer | 4 |
| AstraZeneca | 2 |
| Novo Nordisk A/S | 2 |
| Bristol-Myers Squibb | 1 |
| Korea University Guro Hospital | 1 |
| Novartis Pharmaceuticals | 1 |
| Regeneron Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Heart Failure | 12 |
| Diabetes Mellitus, Type 2 | 2 |
| Cerebrovascular Disorders | 1 |
| Diabetes Mellitus | 1 |
| Diabetic Nephropathies | 1 |
| Hyperglycemia | 1 |
| Hypertension | 1 |
| Obesity | 1 |
| Renal Insufficiency | 1 |
| Renal Insufficiency, Chronic | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.